Turning biodefense dollars into products.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17287749.
- Also identified by PMC identifier 7097580.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Five years after the US anthrax attacks, and more than two years after BioShield legislation was ratified, a survey reveals that biodefense funding has thus far produced only a handful of products for clinical development.
Medical subject headings
- Biotechnology
- Bioterrorism
- Civil Defense
- Clinical Medicine
- Drug Industry
- Technology Transfer
- Vaccines